For now, Cagrilintide provides limited distribution in the continent. Even though clinical trials showed significant potential for patients living with the disease, wider availability is still a challenge. Market clearance across various nations are vital to guarantee {widespread adoption and patient benefit. Upcoming milestones {regarding financia